Showing results (471-480 of 626) with videos related to
Sort By:
Pageof 63
Journal of the American Academy of Dermatology|December 6, 2022
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trialLisa A Beck, Thomas Bieber, Stephan Weidinger, et al.JAMA Dermatology|April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus StatementJoseph F Merola, Beth A Childs, Brooke R Bartley, et al.The British Journal of Dermatology|March 3, 2021
Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohortA R Mulick, K E Mansfield, R J Silverwood, et al.The Journal of Dermatological Treatment|May 12, 2024
Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trialsAdelaide A Hebert, Carsten Flohr, H Chih-Ho Hong, et al.Journal of the American Academy of Dermatology|October 26, 2017
The spectrum of manifestations in desmoplakin gene (DSP) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumabAmy S Paller, Tali Czarnowicki, Yael Renert-Yuval, et al.Dermatitis : Contact, Atopic, Occupational, Drug|February 4, 2026
Epidemiology of Adult Atopic Dermatitis in High-Burden Skin Areas: Results From a Cross-Sectional Patient SurveyAmalie Thorsti Møller Rønnstad, Mia-Louise Nielsen, Anne-Sofie Halling, et al.The Journal of Allergy and Clinical Immunology|September 10, 2016
Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 yearElizabeth A Kennedy, Jennifer Connolly, Jonathan O'B Hourihane, et al.The Journal of Allergy and Clinical Immunology|March 8, 2008
The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort studyJohn Henderson, Kate Northstone, Simon P Lee, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 27, 2023
Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS)Guillaume Canaud, Juan Carlos Lopez Gutierrez, Alan D Irvine, et al.The British Journal of Ophthalmology|June 27, 2002
A novel mutation in KRT12 associated with Meesmann's epithelial corneal dystrophyA D Irvine, C M Coleman, J E Moore, et al.Pageof 63